Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice


Catapano A. L. , Lautsch D., Tokgozoglu L., Ferrieres J., Horack M., Farnier M., ...More

ATHEROSCLEROSIS, vol.252, pp.1-8, 2016 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 252
  • Publication Date: 2016
  • Doi Number: 10.1016/j.atherosclerosis.2016.07.007
  • Journal Name: ATHEROSCLEROSIS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.1-8

Abstract

Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. The percentage of patients with possible or probable FH in various countries was examined in the Dyslipidemia International Study (DYSIS).